Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery system

scientific article

Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery system is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1015870782
P356DOI10.1186/S12941-017-0178-0
P932PMC publication ID5240302
P698PubMed publication ID28095918

P50authorIslam M GhaziQ61112484
P2093author name stringDavid P Nicolau
Mordechai Grupper
P2860cites workMicrobiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia.Q50981341
Gentamicin Treatment of Staphylococcal InfectionsQ70569146
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumoniaQ33612643
The postantibiotic effect: a review of in vitro and in vivo dataQ33617455
Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organismsQ33694513
Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycinQ35111428
The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary studyQ37192126
In vitro models for the study of antibiotic activitiesQ39694601
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.Q39828435
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumoniaQ40675239
Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenemQ40913492
Effect of pulmonary surfactant on antimicrobial activity in vitroQ42049487
Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitalsQ42204946
In Vitro Antibacterial Activity of Amikacin, a New Aminoglycoside, Against Clinical Bacterial Isolates from ChildrenQ43590856
Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impactQ46494181
Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients.Q46839239
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectamikacinQ408529
drug deliveryQ1392806
infectious diseaseQ18123741
P304page(s)2
P577publication date2017-01-17
P1433published inAnnals of Clinical Microbiology and AntimicrobialsQ15765734
P1476titleAnti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery system
P478volume16

Search more.